GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention medication

GLP-1 users saw lower risks of heart attack and stroke

The lead author anticipated GLP-1s would improve blood sugar more than metformin. Other findings were harder to predict.

Fat jabs better than diabetes drug at prevention, analysis finds

Researchers found people taking the injections have a 31 per cent lower risk of developing the disease than those taking metformin.

GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention medication

GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication metformin among people with prediabetes, according to new, independent, preliminary research presented at the American Heart Association's Scientific Sessions 2026, held Nov. 6–9 in Chicago.

GLP-1 Users Saw Lower Risks of Heart Attack and Stroke in Major Study

GLP-1 medications have become synonymous with weight loss. But a major new study of more than a quarter of a million adults suggests their biggest benefits may extend far beyond the number on the scale. People taking the weight loss drugs had lower risks of heart attack, stroke, heart failure,…